These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. 6beta-Acyloxy(nor)tropanes: affinities for antagonist/agonist binding sites on transfected and native muscarinic receptors. Daly JW; Gupta TH; Padgett WL; Pei XF J Med Chem; 2000 Jun; 43(13):2514-22. PubMed ID: 10891110 [TBL] [Abstract][Full Text] [Related]
3. Synthesis and biological characterization of 1,4,5,6-tetrahydropyrimidine and 2-amino-3,4,5,6-tetrahydropyridine derivatives as selective m1 agonists. Messer WS; Abuh YF; Liu Y; Periyasamy S; Ngur DO; Edgar MA; El-Assadi AA; Sbeih S; Dunbar PG; Roknich S; Rho T; Fang Z; Ojo B; Zhang H; Huzl JJ; Nagy PI J Med Chem; 1997 Apr; 40(8):1230-46. PubMed ID: 9111297 [TBL] [Abstract][Full Text] [Related]
4. Functional comparison of muscarinic partial agonists at muscarinic receptor subtypes hM1, hM2, hM3, hM4 and hM5 using microphysiometry. Wood MD; Murkitt KL; Ho M; Watson JM; Brown F; Hunter AJ; Middlemiss DN Br J Pharmacol; 1999 Apr; 126(7):1620-4. PubMed ID: 10323594 [TBL] [Abstract][Full Text] [Related]
5. Effects of clozapine on rat striatal muscarinic receptors coupled to inhibition of adenylyl cyclase activity and on the human cloned m4 receptor. Olianas MC; Maullu C; Onali P Br J Pharmacol; 1997 Oct; 122(3):401-8. PubMed ID: 9351494 [TBL] [Abstract][Full Text] [Related]
6. The interaction of the enantiomers of aceclidine with subtypes of the muscarinic receptor. Ehlert FJ; Griffin MT; Glidden PF J Pharmacol Exp Ther; 1996 Dec; 279(3):1335-44. PubMed ID: 8968358 [TBL] [Abstract][Full Text] [Related]
7. Interaction of neuromuscular blocking drugs with recombinant human m1-m5 muscarinic receptors expressed in Chinese hamster ovary cells. Cembala TM; Sherwin JD; Tidmarsh MD; Appadu BL; Lambert DG Br J Pharmacol; 1998 Nov; 125(5):1088-94. PubMed ID: 9846649 [TBL] [Abstract][Full Text] [Related]
8. SB 202026: a novel muscarinic partial agonist with functional selectivity for M1 receptors. Loudon JM; Bromidge SM; Brown F; Clark MS; Hatcher JP; Hawkins J; Riley GJ; Noy G; Orlek BS J Pharmacol Exp Ther; 1997 Dec; 283(3):1059-68. PubMed ID: 9399977 [TBL] [Abstract][Full Text] [Related]
10. Different agonist-receptor active conformations for rat brain M1 and M2 muscarinic receptors that are separately coupled to two biochemical effector systems. McKinney M; Anderson D; Vella-Rountree L Mol Pharmacol; 1989 Jan; 35(1):39-47. PubMed ID: 2536467 [TBL] [Abstract][Full Text] [Related]
11. Differential coupling of m1, m2 and m3 muscarinic receptor subtypes to inositol 1,4,5-trisphosphate and adenosine 3',5'-cyclic monophosphate accumulation in Chinese hamster ovary cells. Burford NT; Tobin AB; Nahorski SR J Pharmacol Exp Ther; 1995 Jul; 274(1):134-42. PubMed ID: 7616390 [TBL] [Abstract][Full Text] [Related]
12. Selectivity profile of muscarinic toxin 3 in functional assays of cloned and native receptors. Olianas MC; Ingianni A; Maullu C; Adem A; Karlsson E; Onali P J Pharmacol Exp Ther; 1999 Jan; 288(1):164-70. PubMed ID: 9862767 [TBL] [Abstract][Full Text] [Related]
13. The quaternary transformation products of N-(3-chloropropyl)-4-piperidinyl diphenylacetate and N-(2-chloroethyl)-4-piperidinyl diphenylacetate (4-DAMP mustard) have differential affinity for subtypes of the muscarinic receptor. Ehlert FJ; Oliff HS; Griffin MT J Pharmacol Exp Ther; 1996 Feb; 276(2):405-10. PubMed ID: 8632303 [TBL] [Abstract][Full Text] [Related]
14. Aliphatic and heterocyclic analogues of arecaidine propargyl ester. Structure-activity relationships of mono- and bivalent ligands at muscarinic M1 (M4), M2 and M3 receptor subtypes. Moser U; Gubitz C; Galvan M; Immel-Sehr A; Lambrecht G; Mutshcler E Arzneimittelforschung; 1995 Apr; 45(4):449-55. PubMed ID: 7779140 [TBL] [Abstract][Full Text] [Related]
15. Muscarinic subtype affinity and functional activity profile of 1-methyl-2-(2-methyl-1,3-dioxolan-4-yl)pyrrolidine and 1-methyl-2-(2-methyl-1,3-oxathiolan-5-yl)pyrrolidine derivatives. Dei S; Angeli P; Bellucci C; Buccioni M; Gualtieri F; Marucci G; Manetti D; Matucci R; Romanelli MN; Scapecchi S; Teodori E Biochem Pharmacol; 2005 Jun; 69(11):1637-45. PubMed ID: 15896343 [TBL] [Abstract][Full Text] [Related]
16. Functional effects of the muscarinic receptor agonist, xanomeline, at 5-HT1 and 5-HT2 receptors. Watson J; Brough S; Coldwell MC; Gager T; Ho M; Hunter AJ; Jerman J; Middlemiss DN; Riley GJ; Brown AM Br J Pharmacol; 1998 Dec; 125(7):1413-20. PubMed ID: 9884068 [TBL] [Abstract][Full Text] [Related]
17. Thiochrome enhances acetylcholine affinity at muscarinic M4 receptors: receptor subtype selectivity via cooperativity rather than affinity. Lazareno S; Dolezal V; Popham A; Birdsall NJ Mol Pharmacol; 2004 Jan; 65(1):257-66. PubMed ID: 14722259 [TBL] [Abstract][Full Text] [Related]
18. Universal template approach to drug design: polyamines as selective muscarinic receptor antagonists. Bolognesi ML; Minarini A; Budriesi R; Cacciaguerra S; Chiarini A; Spampinato S; Tumiatti V; Melchiorre C J Med Chem; 1998 Oct; 41(21):4150-60. PubMed ID: 9767650 [TBL] [Abstract][Full Text] [Related]
19. Functional selectivity of muscarinic receptor antagonists for inhibition of M3-mediated phosphoinositide responses in guinea pig urinary bladder and submandibular salivary gland. Nelson CP; Gupta P; Napier CM; Nahorski SR; Challiss RA J Pharmacol Exp Ther; 2004 Sep; 310(3):1255-65. PubMed ID: 15140916 [TBL] [Abstract][Full Text] [Related]
20. An agonist that is selective for adenylate cyclase-coupled muscarinic receptors. Baumgold J; Drobnick A Mol Pharmacol; 1989 Sep; 36(3):465-70. PubMed ID: 2550780 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]